A U.K. lab has a plan to make potential coronavirus vaccine available at lowest possible price
Imperial College London, which is about to launch a combined first and second phase of coronavirus vaccine testing on June 15, is aiming to make sure its product is available at the lowest possible price in the United Kingdom and several other countries if it proves to be safe and effective, The New York Times reports.
Scientists and health experts have called for any successful vaccine to be distributed at low cost with need prioritized over profit, but since major pharmaceutical companies and biotechnology startups have so far led the development race, it's unclear whether that will happen. The vaccine Imperial College is developing is reportedly cheap and easy to manufacture, so the university is creating a "social enterprise" in partnership with the Hong Kong-based investment firm Morningside Ventures called VacEquity Global Health. The company will be for-profit, but Imperial College has promised to make the vaccine available at the lowest possible cost in the U.K. and low- and middle-income countries. It may charge more for wealthier countries like the United States or Singapore, however.
Meanwhile, scientists are reportedly close to a breakthrough when it comes to antibody therapy, according to pharmaceutical company AstraZeneca. The potential treatment, which involves the injection of cloned antibodies that counteract COVID-19, could reportedly prove significant for people in the early stages of infection. If the treatment winds up being successful, it will be more expensive than vaccine production, so the therapy would likely be targeted at the elderly and other vulnerable people who may struggle to develop a "good response to a vaccine." Read more at The New York Times and The Guardian.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published